Recombinant Human ITGB2 Protein-6His-ABP tag-CTP-198(Cat#: CTP-198)

This product is a 31 kDa recombinant human ITGB2 protein Antigen with a N-terminal His6-ABP tag expressed in the E.coli. It is available for Antibody Competition.

Summary Related Products & Services

Specifications
Expressed Host E. Coli
Specie Reactivity Human
Target CD18
Molecule Mass 31 kDa
Purity >80% by SDS-PAGE and Coomassie Blue staining
Formulation PBS and 1M Urea, pH 7.4
Applications AC
Product Form Liquid
Storage Store at -20/-80°C. Aliquot to avoid repeated freezing and thawing.
Protein Information
Introduction Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. Integrin ITGAL/ITGB2 is also a receptor for the secreted form of ubiquitin-like protein ISG15; the interaction is mediated by ITGAL. Integrins ITGAM/ITGB2 and ITGAX/ITGB2 are receptors for the iC3b fragment of the third complement component and for fibrinogen. Integrin ITGAX/ITGB2 recognizes the sequence G-P-R in fibrinogen alpha-chain. Integrin ITGAM/ITGB2 recognizes P1 and P2 peptides of fibrinogen gamma chain. Integrin ITGAM/ITGB2 is also a receptor for factor X. Integrin ITGAD/ITGB2 is a receptor for ICAM3 and VCAM1. Contributes to natural killer cell cytotoxicity. Involved in leukocyte adhesion and transmigration of leukocytes including T-cells and neutrophils. Triggers neutrophil transmigration during lung injury through PTK2B/PYK2-mediated activation. Integrin ITGAL/ITGB2 in association with ICAM3, contributes to apoptotic neutrophil phagocytosis by macrophages. In association with alpha subunit ITGAM/CD11b, required for CD177-PRTN3-mediated activation of TNF primed neutrophils.
Alternative Names Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta; Complement receptor C3 subunit beta; CD_antigen: CD18; Leukocyte Cell Adhesion Molecule CD18; Complement Receptor C3 Beta-Subunit; Macrophage Antigen 1 (Mac-1) Beta Subunit); LAD; CD18; MF17; MFI7; LCAMB; LFA-1; MAC-1
Gene ID 3689
UniProt ID P05107
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry